Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Thyroid : Official Journal of the American Thyroid Association|August 19, 2023
Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Risk-adapted management of thyroid cancerR Michael Tuttle
The Lancet. Diabetes & Endocrinology|December 4, 2018
Distinguishing remnant ablation from adjuvant treatment in differentiated thyroid cancerR Michael Tuttle
Endocrine|March 12, 2014
Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?R Michael Tuttle
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
Controversial Issues in Thyroid Cancer ManagementR Michael Tuttle
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Follow up approaches in thyroid cancer: a risk adapted paradigmR Michael Tuttle, Rebecca Leboeuf
Journal of the National Comprehensive Cancer Network : JNCCN|July 12, 2007
Investigational therapies for metastatic thyroid carcinomaR Michael Tuttle, R Leboeuf
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Clinical Assessment and Risk Stratification in Differentiated Thyroid CancerFernanda Vaisman, R Michael Tuttle
The Journal of Clinical Endocrinology and Metabolism|March 9, 2022
Letter to the Editor From Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer"Laura Boucai, R Michael Tuttle
Seminars in Nuclear Medicine|January 29, 2011
Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United StatesGenevieve Rondeau, R Michael Tuttle
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Thyroid : Official Journal of the American Thyroid Association|August 19, 2023
Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Risk-adapted management of thyroid cancerR Michael Tuttle
The Lancet. Diabetes & Endocrinology|December 4, 2018
Distinguishing remnant ablation from adjuvant treatment in differentiated thyroid cancerR Michael Tuttle
Endocrine|March 12, 2014
Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?R Michael Tuttle
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2018
Controversial Issues in Thyroid Cancer ManagementR Michael Tuttle
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Follow up approaches in thyroid cancer: a risk adapted paradigmR Michael Tuttle, Rebecca Leboeuf
Journal of the National Comprehensive Cancer Network : JNCCN|July 12, 2007
Investigational therapies for metastatic thyroid carcinomaR Michael Tuttle, R Leboeuf
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Clinical Assessment and Risk Stratification in Differentiated Thyroid CancerFernanda Vaisman, R Michael Tuttle
The Journal of Clinical Endocrinology and Metabolism|March 9, 2022
Letter to the Editor From Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer"Laura Boucai, R Michael Tuttle
Seminars in Nuclear Medicine|January 29, 2011
Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United StatesGenevieve Rondeau, R Michael Tuttle
Pageof 32